Results 211 to 220 of about 363,573 (256)
Some of the next articles are maybe not open access.
Vascular Endothelial Growth Factor (VEGF) Receptors
1995Abstract Two tyrosine kinases have been recently identified as putative VEGF receptors (deVries et al. 1992; Terman et al. 1992a). The flt-1 (fms-like-tyrosine kinase; Shibuya et al. 1990) and KOR (kinase domain region; Terman et al. 1991) proteins have been shown to bind VEGF with high affinity.
J E Park, N Ferrara
openaire +1 more source
Vascular Endothelial Growth Factor (VEGF)
2016One of the best-validated signalling pathways in angiogenesis is vascular endothelial growth factor (VEGF) and its receptors. VEGF family encompasses 7 VEGF glycoproteins members including, VEGF-A, VEGF-B, VEGF-C, VEGF-D, and VEGF-E and placental growth factors 1 and 2 (PLGF). Of these, the very well-characterized member is VEGF-A. Vascular endothelial
openaire +1 more source
Le VEGF (vascular endothelial growth factor)
Sang thrombose vaisseaux, 2009Auteur(s) : Yasmine Zouggari Inserm 970, PARCC, 56 Rue Leblanc 75015, Paris Les vaisseaux sanguins assurent le transport d’oxygene et de nutriments vers l’ensemble des organes et des tissus. La formation de neo-vaisseaux (ou angiogenese) s’observe dans des conditions physiologiques, lors du developpement embryonnaire et de la croissance.
openaire +1 more source
Vascular Endothelial Growth Factor (VEGF) Inhibition - A Critical Review
Anti-Cancer Agents in Medicinal Chemistry, 2007Angiogenesis, or formation of new blood capillaries from preexisting vessels, plays both beneficial and damaging roles in the organism. It is a result of a complex balance of positive and negative regulators, and vascular endothelial growth factor (VEGF) is one of the most important pro-angiogenic factors involved in tumor angiogenesis.
Irina Sousa, Moreira +2 more
openaire +2 more sources
Vascular endothelial growth factors (VEGF): role in pathological processes
Vestnik oftal'mologii, 2016Russian and foreign literature sources on vascular endothelial growth factors (VEGF) from different parts of the human body, their prevalence and involvement in pathological processes were analyzed. A conclusion has been drawn that further research on different types of VEGF is needed.
Yu A, Borzilova +2 more
openaire +2 more sources
Vascular Endothelial Growth Factor (VEGF) Inhibition by Small Molecules
Journal of Chemotherapy, 2004Angiogenesis is essential for primary tumours to grow and metastasise, and is driven by the production of positive angiogenic factors. The Vascular Endothelial Growth Factor (VEGF) family is central to the process of angiogenesis and comprises 5 molecules designated A, B, C, D and E. VEGF is overexpressed in several solid malignancies.
S I, Ahmed, A L, Thomas, W P, Steward
openaire +2 more sources
ACTIVATED HUMAN NEUTROPHILS EXPRESS VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)
Cytokine, 1998The neutrophil (PMN) influx in the acute inflammatory response is associated with a local increase in vascular permeability and oedema. Vascular endothelial growth factor (VEGF), a growth factor known to have potent vascular permeability-enhancing properties in addition to being an endothelial cell mitogen and a chemo-attractant for mononuclear cells ...
N J, Webb +4 more
openaire +2 more sources
Vascular endothelial growth factor (VEGF) signaling in tumor progression
Critical Reviews in Oncology/Hematology, 2007Vascular endothelial cells are ordinarily quiescent in adult humans and divide less than once per decade. When tumors reach a size of about 0.2-2.0mm in diameter, they become hypoxic and limited in size in the absence of angiogenesis. There are about 30 endogenous pro-angiogenic factors and about 30 endogenous anti-angiogenic factors.
openaire +2 more sources
Cancer treatment and survivorship statistics, 2022
Ca-A Cancer Journal for Clinicians, 2022Kimberly D Miller +2 more
exaly
Vascular Endothelial Growth Factor (VEGF)
2020Alexandra Erdmann, Erin S. Costanzo
openaire +1 more source